This website may contain forward-looking statements within the meaning of applicable securities laws. These statements may include, but are not limited to, statements regarding Lamark’s research and development programs, product candidates, clinical trials, regulatory pathways, collaborations, and commercialization plans. Forward-looking statements are based on current expectations and assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied.

Such risks and uncertainties include, among others, the success of preclinical and clinical studies, regulatory approvals, manufacturing capabilities, market acceptance, competition, intellectual property protection, and financing availability.

Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by applicable law, Lamark undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances.